C164H174N38O5 — CID 158587236
3-[3-(1H-benzimidazol-4-ylmethyl)-5-benzylimidazol-4-yl]prop-1-en-2-amine;3-[3-(3H-benzimidazol-5-ylmethyl)-5-benzylimidazol-4-yl]prop-1-en-2-amine;1-[3-(1H-benzimidazol-4-ylmethyl)-5-phenylimidazol-4-yl]propan-2-ol;1-[3-(3H-benzimidazol-5-ylmethyl)-5-phenylimidazol-4-yl]propan-2-ol;3-[1-(1H-benzimidazol-4-yl)-4-phenylpiperazin-2-yl]propanamide;3-[1-(3H-benzimidazol-5-yl)-4-phenylpiperazin-2-yl]propanamide;3-[5-benzyl-3-(1H-indazol-4-ylmethyl)imidazol-4-yl]prop-1-en-2-amine;3-[1-(2-methyl-3H-benzimidazol-5-yl)-4-phenylpiperazin-2-yl]propanamide (PubChem CID 158587236) has the molecular formula C164H174N38O5 and a molecular weight of 2757.46 g/mol. Its IUPAC name is 3-[3-(1H-benzimidazol-4-ylmethyl)-5-benzylimidazol-4-yl]prop-1-en-2-amine;3-[3-(3H-benzimidazol-5-ylmethyl)-5-benzylimidazol-4-yl]prop-1-en-2-amine;1-[3-(1H-benzimidazol-4-ylmethyl)-5-phenylimidazol-4-yl]propan-2-ol;1-[3-(3H-benzimidazol-5-ylmethyl)-5-phenylimidazol-4-yl]propan-2-ol;3-[1-(1H-benzimidazol-4-yl)-4-phenylpiperazin-2-yl]propanamide;3-[1-(3H-benzimidazol-5-yl)-4-phenylpiperazin-2-yl]propanamide;3-[5-benzyl-3-(1H-indazol-4-ylmethyl)imidazol-4-yl]prop-1-en-2-amine;3-[1-(2-methyl-3H-benzimidazol-5-yl)-4-phenylpiperazin-2-yl]propanamide.
| Compound Name | 3-[3-(1H-benzimidazol-4-ylmethyl)-5-benzylimidazol-4-yl]prop-1-en-2-amine;3-[3-(3H-benzimidazol-5-ylmethyl)-5-benzylimidazol-4-yl]prop-1-en-2-amine;1-[3-(1H-benzimidazol-4-ylmethyl)-5-phenylimidazol-4-yl]propan-2-ol;1-[3-(3H-benzimidazol-5-ylmethyl)-5-phenylimidazol-4-yl]propan-2-ol;3-[1-(1H-benzimidazol-4-yl)-4-phenylpiperazin-2-yl]propanamide;3-[1-(3H-benzimidazol-5-yl)-4-phenylpiperazin-2-yl]propanamide;3-[5-benzyl-3-(1H-indazol-4-ylmethyl)imidazol-4-yl]prop-1-en-2-amine;3-[1-(2-methyl-3H-benzimidazol-5-yl)-4-phenylpiperazin-2-yl]propanamide |
|---|---|
| PubChem CID | 158587236 |
| Molecular Formula | C164H174N38O5 |
| Molecular Weight | 2757.46 g/mol |
| Exact Mass | 2755.45 |
| IUPAC Name | 3-[3-(1H-benzimidazol-4-ylmethyl)-5-benzylimidazol-4-yl]prop-1-en-2-amine;3-[3-(3H-benzimidazol-5-ylmethyl)-5-benzylimidazol-4-yl]prop-1-en-2-amine;1-[3-(1H-benzimidazol-4-ylmethyl)-5-phenylimidazol-4-yl]propan-2-ol;1-[3-(3H-benzimidazol-5-ylmethyl)-5-phenylimidazol-4-yl]propan-2-ol;3-[1-(1H-benzimidazol-4-yl)-4-phenylpiperazin-2-yl]propanamide;3-[1-(3H-benzimidazol-5-yl)-4-phenylpiperazin-2-yl]propanamide;3-[5-benzyl-3-(1H-indazol-4-ylmethyl)imidazol-4-yl]prop-1-en-2-amine;3-[1-(2-methyl-3H-benzimidazol-5-yl)-4-phenylpiperazin-2-yl]propanamide |
| SMILES | C=C(N)Cc1c(Cc2ccccc2)ncn1Cc1ccc2nc[nH]c2c1.C=C(N)Cc1c(Cc2ccccc2)ncn1Cc1cccc2[nH]cnc12.C=C(N)Cc1c(Cc2ccccc2)ncn1Cc1cccc2[nH]ncc12.CC(O)Cc1c(-c2ccccc2)ncn1Cc1ccc2nc[nH]c2c1.CC(O)Cc1c(-c2ccccc2)ncn1Cc1cccc2[nH]cnc12.Cc1nc2ccc(N3CCN(c4ccccc4)CC3CCC(N)=O)cc2[nH]1.NC(=O)CCC1CN(c2ccccc2)CCN1c1ccc2nc[nH]c2c1.NC(=O)CCC1CN(c2ccccc2)CCN1c1cccc2[nH]cnc12 |
| InChI | InChI=1S/C21H25N5O.3C21H21N5.2C20H23N5O.2C20H20N4O/c1-15-23-19-9-7-17(13-20(19)24-15)26-12-11-25(16-5-3-2-4-6-16)14-18(26)8-10-21(22)27;1-15(22)10-21-20(11-16-6-3-2-4-7-16)23-14-26(21)13-17-8-5-9-19-18(17)12-24-25-19;1-15(22)10-20-19(11-16-6-3-2-4-7-16)25-14-26(20)12-17-8-5-9-18-21(17)24-13-23-18;1-15(22)9-21-20(10-16-5-3-2-4-6-16)25-14-26(21)12-17-7-8-18-19(11-17)24-13-23-18;21-19(26)10-9-16-13-24(15-5-2-1-3-6-15)11-12-25(16)18-8-4-7-17-20(18)23-14-22-17;21-20(26)9-7-17-13-24(15-4-2-1-3-5-15)10-11-25(17)16-6-8-18-19(12-16)23-14-22-18;1-14(25)10-18-20(15-6-3-2-4-7-15)23-13-24(18)11-16-8-5-9-17-19(16)22-12-21-17;1-14(25)9-19-20(16-5-3-2-4-6-16)23-13-24(19)11-15-7-8-17-18(10-15)22-12-21-17/h2-7,9,13,18H,8,10-12,14H2,1H3,(H2,22,27)(H,23,24);2-9,12,14H,1,10-11,13,22H2,(H,24,25);2-9,13-14H,1,10-12,22H2,(H,23,24);2-8,11,13-14H,1,9-10,12,22H2,(H,23,24);1-8,14,16H,9-13H2,(H2,21,26)(H,22,23);1-6,8,12,14,17H,7,9-11,13H2,(H2,21,26)(H,22,23);2-9,12-14,25H,10-11H2,1H3,(H,21,22);2-8,10,12-14,25H,9,11H2,1H3,(H,21,22) |
| InChIKey | HTZCERXGNFKCTN-UHFFFAOYSA-N |
| XLogP | 24.92 |
| TPSA | 585.77 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 43 |
| Heavy Atoms | 207 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2757.46 |
| LogP ≤ 5 | 24.92 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 32 |